Search

everythinglearnresearchcommunity

for

Search:↓

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Scalp sarcoidosis can cause hair loss and needs accurate diagnosis and treatment with specific medications.

Exosomes could revolutionize skin disease treatment and healing.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Transplant patients often get skin problems, with treatments varying by condition.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Aging affects hair density and skin health, and Behcet's disease, a complex condition with no specific test, involves sores and systemic issues, treated with various medications.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Hydroxychloroquine may help COVID-19 patients with lupus.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Heparin treatment may help manage pemphigus vulgaris in dogs.

A patient regrew hair after a lung transplant using standard post-transplant medication.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.